Trademark: 90788862
Word
TELIGENE
Status
Dead
Status Code
713
Status Date
Friday, February 23, 2024
Serial Number
90788862
Registration Number
7003128
Registration Date
Tuesday, March 21, 2023
Mark Type
3000
Filing Date
Tuesday, June 22, 2021
Published for Opposition
Tuesday, January 3, 2023
Cancellation Date
Friday, February 23, 2024

Trademark Owner History
Suzhou Teligene LTD - Original Registrant

Classifications
5 Medicines for human purposes for the treatment of cancer; medicine for human purpose for the treatment of gastrointestinal system, respiratory system, genitourinary system, endocrine system, nervous system, circulatory system and musculoskeletal system related diseases and for the treatment of colds and flu, skin diseases, tumors, dental and oral diseases; capsules for medicines, namely, coated capsule medicines for prevention and treatment of human diseases, namely, central nervous system diseases, peripheral nervous system diseases, circulatory system diseases, digestive system diseases, antipyretic and analgesic purposes, non-steroidal anti-inflammatory purpose, infectious diseases, autoimmune diseases, anti-tumor purposes, hypoglycemic and diuretic purposes, vitamin and hormonal purposes; pharmaceutical preparations for the treatment of hematological, autoimmune, inflammatory and respiratory diseases and disorders; biochemical medicines, for treating diseases of cardiovascular system, for treating diseases of cerebrovascular system, for use in antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of immune system and musculo-skeletal system; drugs for medical purposes, namely, pharmaceutical preparations for treating neurological disease, muscular disease, ischemic disease, renal disease, cancer; medicated ointments for pharmaceutical purposes, namely, antibiotic ointments, antiseptic ointments, anti-itch ointments, anti-viral ointments, medicated sunburn ointments; chemico-pharmaceutical preparations for the treatment of central nervous system diseases, cancer and metabolic diseases; medicines in tablet form for the treatment of muscle injuries and disorders and sports related injuries and for increasing antioxidant levels, maintaining cholesterol and improving exercise, endurance, capacity, performance and cardiovascular health; drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; biological preparations for medical purposes for the treatment of hereditary diseases, metabolic diseases, oncological diseases and complex multigenic diseases; anti-cancer preparations; biological preparations for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the prevention and treatment of cancer; biochemical medicines for the treatment of cancer; liquid medicines for the treatment of cancer
The mark consists of a design of circle and crescent to the left and stylized word TELIGENE appearing to the right.

Trademark Events
Feb 23, 2024
Cancellation Terminated No. 999999
Feb 23, 2024
Cancelled Section 18-Total
Feb 22, 2024
Cancellation Granted No. 999999
Nov 21, 2023
Cancellation Instituted No. 999999
Mar 21, 2023
Notice Of Registration Confirmation Emailed
Mar 21, 2023
Registered-Principal Register
Jan 3, 2023
Official Gazette Publication Confirmation E-Mailed
Jan 3, 2023
Published For Opposition
Dec 14, 2022
Notification Of Notice Of Publication E-Mailed
Nov 17, 2022
1(B) Basis Deleted; New Basis Requested
Nov 17, 2022
Notice Of Allowance Cancelled
Nov 17, 2022
Petition To Director - Change Basis - Granted
Nov 16, 2022
Assigned To Petition Staff
Nov 3, 2022
Teas Petition To Amend Basis Received
Jun 28, 2022
Noa E-Mailed - Sou Required From Applicant
May 3, 2022
Official Gazette Publication Confirmation E-Mailed
May 3, 2022
Published For Opposition
Apr 13, 2022
Notification Of Notice Of Publication E-Mailed
Mar 29, 2022
Approved For Pub - Principal Register
Mar 29, 2022
Examiner's Amendment Entered
Mar 29, 2022
Notification Of Examiners Amendment E-Mailed
Mar 29, 2022
Examiners Amendment E-Mailed
Mar 29, 2022
Examiners Amendment -Written
Mar 12, 2022
Assigned To Examiner
Sep 8, 2021
Notice Of Design Search Code E-Mailed
Sep 7, 2021
New Application Office Supplied Data Entered
Jun 25, 2021
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24